• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Alcon

Alcon

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Research and Markets: Glaucoma - Pipeline Review, H1 2015 - Featuring 50 Companies & 104 Drug Profiles

    Research and Markets: Glaucoma - Pipeline Review, H1 2015 - Featuring 50 Companies & 104 Drug Profiles

  2. Research and Markets: Wet (Neovascular / Exudative) Macular Degeneration Therapeutics Pipeline Review 2015: 41 Companies

    Research and Markets: Wet (Neovascular / Exudative) Macular Degeneration Therapeutics Pipeline Review 2015: 41 Companies

  3. Money Lessons From Baseball

    Alcon benefits from leadership positions across eye care.

  4. Healthcare on the Rebound

    The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...

  5. Blockbusters Differentiate Novartis

    The company's diverse operating divisions and robust pipeline should lead to steady growth.

  6. February/March 2010 Picks

    Four offerings deemed to be right for right now.

  7. Simplicity Is a Virtue for This Fund

    BBH Core Select manager Tim Hartch says focusing on easy-to-understand businesses, particularly in the financials and consumer defensive sectors, helps his team avoid negative surprises.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.